Navigation Links
SomaLogic and New England Biolabs announce agreement to use SOMAmers for multiple PCR products
Date:7/27/2011

Boulder, CO and Ipswich, MA (July 27, 2011) SomaLogic, Inc. and New England Biolabs, Inc. (NEB) announce today that they have entered into an exclusive licensing agreement whereby SomaLogic will provide specific SOMAmers as critical and unique reagents in several current and future NEB nucleic acid amplification and polymerase chain reaction (PCR) products.

SOMAmers are specific protein binding reagents based on chemically modified "aptamers," or short single-stranded nucleic acids. Although SOMAmers have nearly unlimited potential in many different proteomic applications (e.g., biomarker discovery and validation, clinical diagnostics, drug discovery and development), NEB is incorporating specific SOMAmers into their products as reversible inhibitors of thermally active DNA polymerases used in PCR (e.g., NEB's OneTaqTM Hot Start DNA Polymerase).

"We are delighted that our colleagues at New England Biolabs see the utility of SOMAmers in enhancing and differentiating their outstanding laboratory solutions from their many competitors," said Nebojsa Janjic, Chief Science Officer of SomaLogic. "We look forward to working with them to further explore and apply the distinct advantages of our powerful technology in research laboratory settings."

"There are many opportunities to further enhance the performance of thermally active DNA polymerases in PCR reactions," states Dr. Salvatore Russello, Associate Director of Business Development at NEB. "This agreement is thus of great value to NEB, and is already being used to improve the application of DNA polymerases, such as OneTaq Hot Start."

Terms of the agreement were not disclosed.


'/>"/>

Contact: Fintan Steele, Ph.D.
fsteele@somalogic.com
SomaLogic, Inc.
Source:Eurekalert

Page: 1

Related biology news :

1. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
2. Study: Illegal fishing harming present and future New England groundfish fisheries
3. Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax
4. LSUHSCs England plays key role in developing new ALS treatment guidelines
5. Researchers issue outlook for a significant New England red tide in 2010
6. Researchers discover potential solutions to New England roadside erosion
7. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
8. 2008 SNM Wagner-Torizuka Fellowships announced
9. NIAID announces 25 new awards to develop radiation countermeasures
10. Aware Announces Q3 2008 Earnings Conference Call
11. Governor Doyle announces historic genomic research collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... N.Y. and ITHACA, N.Y. ... ) and Cornell University, a leader in dairy research, ... with bioinformatics designed to help reduce the chances that ... With the onset of this dairy project, Cornell University ... Consortium for Sequencing the Food Supply Chain, a food ...
(Date:5/16/2017)...   Bridge Patient Portal , an enterprise ... EMR Systems , an electronic medical record solutions ... established a partnership to build an interface between ... Centricity™ products, including Centricity Practice Solution (CPS), Centricity ... new integrations will allow healthcare delivery networks using ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert in ... media edge server, the M820, which features the company,s hybrid codec ... provided by Tera Probe, Inc., will be showcased during the upcoming ... NAB show at the Las Vegas Convention ... Click ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... New York, NY (PRWEB) , ... October 12, ... ... York Academy of Sciences today announced the three Winners and six Finalists of ... Awards are given annually by the Blavatnik Family Foundation and administered by the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, ... in analytical testing are being attributed to new regulatory requirements for all new ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
Breaking Biology Technology: